Mindfulness-assisted Psychedelic Therapy
Phase 2
40
about 2.1 years
25+
1 site in CA
What this study is about
This trial is testing whether mindfulness training enhances the effects of psychedelic therapy (psilocybin) on mental health. Participants will receive either psilocybin alone or psilocybin combined with mindfulness training, and their responses to questionnaires, cognitive tests, and brain activity measurements will be assessed throughout it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Psilocybin
- 2.Take Psilocybin plus mindfulness training
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oral
Primary: Change in stress symptoms
Secondary: Mean severity of adverse events, Number of participants reporting adverse events